422 related articles for article (PubMed ID: 26860517)
1. Identification of several circulating microRNAs from a genome-wide circulating microRNA expression profile as potential biomarkers for impaired glucose metabolism in polycystic ovarian syndrome.
Jiang L; Huang J; Chen Y; Yang Y; Li R; Li Y; Chen X; Yang D
Endocrine; 2016 Jul; 53(1):280-90. PubMed ID: 26860517
[TBL] [Abstract][Full Text] [Related]
2. Circulating microRNAs in patients with polycystic ovary syndrome.
Ding CF; Chen WQ; Zhu YT; Bo YL; Hu HM; Zheng RH
Hum Fertil (Camb); 2015 Mar; 18(1):22-9. PubMed ID: 25268995
[TBL] [Abstract][Full Text] [Related]
3. Characterization of microRNA profile in human cumulus granulosa cells: Identification of microRNAs that regulate Notch signaling and are associated with PCOS.
Xu B; Zhang YW; Tong XH; Liu YS
Mol Cell Endocrinol; 2015 Mar; 404():26-36. PubMed ID: 25622783
[TBL] [Abstract][Full Text] [Related]
4. MiRNAs expression profiling of rat ovaries displaying PCOS with insulin resistance.
Zhang C; Yu C; Lin Z; Pan H; Li K; Ma H
Arch Gynecol Obstet; 2020 Nov; 302(5):1205-1213. PubMed ID: 32757043
[TBL] [Abstract][Full Text] [Related]
5. Increased MicroRNA Levels in Women With Polycystic Ovarian Syndrome but Without Insulin Resistance: A Pilot Prospective Study.
Butler AE; Ramachandran V; Cunningham TK; David R; Gooderham NJ; Benurwar M; Dargham SR; Hayat S; Sathyapalan T; Najafi-Shoushtari SH; Atkin SL
Front Endocrinol (Lausanne); 2020; 11():571357. PubMed ID: 33101204
[TBL] [Abstract][Full Text] [Related]
6. miR-483-5p and miR-486-5p are down-regulated in cumulus cells of metaphase II oocytes from women with polycystic ovary syndrome.
Shi L; Liu S; Zhao W; Shi J
Reprod Biomed Online; 2015 Oct; 31(4):565-72. PubMed ID: 26283014
[TBL] [Abstract][Full Text] [Related]
7. Validation of circulating microRNAs miR-142-3p and miR-598-3p in women with polycystic ovary syndrome as potential diagnostic markers.
Insenser M; Quintero A; de Lope S; Álvarez-Blasco F; Martínez-García MÁ; Luque-Ramírez M; Escobar-Morreale HF
Hum Reprod; 2023 May; 38(5):951-960. PubMed ID: 36931262
[TBL] [Abstract][Full Text] [Related]
8. Differential expression profile of plasma exosomal microRNAs in women with polycystic ovary syndrome.
Jiang X; Li J; Zhang B; Hu J; Ma J; Cui L; Chen ZJ
Fertil Steril; 2021 Mar; 115(3):782-792. PubMed ID: 33041053
[TBL] [Abstract][Full Text] [Related]
9. Circulating miRNAs in Women with Polycystic Ovary Syndrome: A Longitudinal Cohort Study.
Udesen PB; Sørensen AE; Svendsen R; Frisk NLS; Hess AL; Aziz M; Wissing MLM; Englund ALM; Dalgaard LT
Cells; 2023 Mar; 12(7):. PubMed ID: 37048055
[TBL] [Abstract][Full Text] [Related]
10. Circulatory microRNA 23a and microRNA 23b and polycystic ovary syndrome (PCOS): the effects of body mass index and sex hormones in an Eastern Han Chinese population.
Xiong W; Lin Y; Xu L; Tamadon A; Zou S; Tian F; Shao R; Li X; Feng Y
J Ovarian Res; 2017 Feb; 10(1):10. PubMed ID: 28193283
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis.
Sathyapalan T; David R; Gooderham NJ; Atkin SL
Sci Rep; 2015 Nov; 5():16890. PubMed ID: 26582398
[TBL] [Abstract][Full Text] [Related]
12. Characterization of serum microRNAs profile of PCOS and identification of novel non-invasive biomarkers.
Long W; Zhao C; Ji C; Ding H; Cui Y; Guo X; Shen R; Liu J
Cell Physiol Biochem; 2014; 33(5):1304-15. PubMed ID: 24802714
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of Heqi san on rat model of polycystic ovary syndrome through the PI3K/AKT pathway.
Zhao H; Zhou D; Chen Y; Liu D; Chu S; Zhang S
Daru; 2017 Oct; 25(1):21. PubMed ID: 29020999
[TBL] [Abstract][Full Text] [Related]
14. Plasma omentin-1 levels are reduced in non-obese women with normal glucose tolerance and polycystic ovary syndrome.
Choi JH; Rhee EJ; Kim KH; Woo HY; Lee WY; Sung KC
Eur J Endocrinol; 2011 Nov; 165(5):789-96. PubMed ID: 21865408
[TBL] [Abstract][Full Text] [Related]
15. Identification of microRNAs in human follicular fluid: characterization of microRNAs that govern steroidogenesis in vitro and are associated with polycystic ovary syndrome in vivo.
Sang Q; Yao Z; Wang H; Feng R; Wang H; Zhao X; Xing Q; Jin L; He L; Wu L; Wang L
J Clin Endocrinol Metab; 2013 Jul; 98(7):3068-79. PubMed ID: 23666971
[TBL] [Abstract][Full Text] [Related]
16. Identification of differentially expressed microRNAs in the ovary of polycystic ovary syndrome with hyperandrogenism and insulin resistance.
Lin L; Du T; Huang J; Huang LL; Yang DZ
Chin Med J (Engl); 2015 Jan; 128(2):169-74. PubMed ID: 25591557
[TBL] [Abstract][Full Text] [Related]
17. Identification of miR-16-5p and miR-155-5p microRNAs differentially expressed in circulating leukocytes of pregnant women with polycystic ovary syndrome and gestational diabetes.
Hocaoglu M; Demirer S; Loclar Karaalp I; Kaynak E; Attar E; Turgut A; Karateke A; Komurcu-Bayrak E
Gynecol Endocrinol; 2021 Mar; 37(3):216-220. PubMed ID: 33148068
[TBL] [Abstract][Full Text] [Related]
18. Low Circulating Levels of miR-451a in Girls with Polycystic Ovary Syndrome: Different Effects of Randomized Treatments.
Díaz M; Bassols J; López-Bermejo A; de Zegher F; Ibáñez L
J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31730174
[TBL] [Abstract][Full Text] [Related]
19. Identification of microRNAs and genes associated with hyperandrogenism in the follicular fluid of women with polycystic ovary syndrome.
Xue Y; Lv J; Xu P; Gu L; Cao J; Xu L; Xue K; Li Q
J Cell Biochem; 2018 May; 119(5):3913-3921. PubMed ID: 29193229
[TBL] [Abstract][Full Text] [Related]
20. Testosterone to dihydrotestosterone ratio as a new biomarker for an adverse metabolic phenotype in the polycystic ovary syndrome.
Münzker J; Hofer D; Trummer C; Ulbing M; Harger A; Pieber T; Owen L; Keevil B; Brabant G; Lerchbaum E; Obermayer-Pietsch B
J Clin Endocrinol Metab; 2015 Feb; 100(2):653-60. PubMed ID: 25387259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
